Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome

被引:10
|
作者
Kuzuoglu-Ozturk, Duygu [1 ,2 ]
Hu, Zhiqiang [3 ]
Rama, Martina [1 ,2 ]
Devericks, Emily [1 ,2 ]
Weiss, Jacob [1 ,2 ]
Chiang, Gary G. [4 ]
Worland, Stephen T. [4 ]
Brenner, Steven E. [3 ]
Goodarzi, Hani [1 ,2 ,5 ]
Gilbert, Luke A. [1 ,2 ]
Ruggero, Davide [1 ,2 ,6 ]
机构
[1] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA
[3] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA
[4] eFFECTOR Therapeut, San Diego, CA 92121 USA
[5] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA
[6] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
来源
CELL REPORTS | 2021年 / 35卷 / 13期
关键词
STRESS-RESPONSE; HIGH EXPRESSION; INITIATION; MITOCHONDRIA; REPRESSION; AUTOPHAGY; ACTIVATE; BINDING; UPRMT;
D O I
10.1016/j.celrep.2021.109321
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protein required for translation of all eukaryotic genomes, is a surprising yet potent oncogenic driver. The genetic interactions that maintain the oncogenic activity of this key translation factor remain unknown. In this study, we carry out a genome-wide CRISPRi screen wherein we identify more than 600 genetic interactions that sustain eIF4E oncogenic activity. Our data show that eIF4E controls the translation of Tfeb, a key executer of the autophagy response. This autophagy survival response is triggered by mitochondrial proteotoxic stress, which allows cancer cell survival. Our screen also reveals a functional interaction between eIF4E and a single anti-apoptotic factor, Bcl-xL, in tumor growth. Furthermore, we show that eIF4E and the exon-junction complex (EJC), which is involved in many steps of RNA metabolism, interact to control the migratory properties of cancer cells. Overall, we uncover several cancer-specific vulnerabilities that provide further resolution of the cancer translatome.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Scientists screen embryo for genetic predisposition to cancer
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7301): : 1505 - 1505
  • [22] Integrative analysis of molecular genetic targets and pathways in colorectal cancer through screening large-scale microarray data
    Onur, Elif
    Denkceken, Tuba
    INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS, 2021, 26 (1-2) : 81 - 98
  • [23] Genetic pathways in cervical cancer progression
    不详
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 : 30 - 30
  • [24] Genetic pathways linking hemostasis and cancer
    Garnier, Delphine
    Magnus, Nathalie
    D'Asti, Esterina
    Hashemi, Maryam
    Meehan, Brian
    Milsom, Chloe
    Rak, Janusz
    THROMBOSIS RESEARCH, 2012, 129 : S22 - S29
  • [25] Unraveling the Progression of Colon Cancer Pathogenesis Through Epigenetic Alterations and Genetic Pathways
    Fard, Asal Abolghasemi
    Mahmoodzadeh, Afshin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [26] Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment
    Roy-Luzarraga, Marina
    Hodivala-Dilke, Kairbaan
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3718 - 3724
  • [27] Genetic and molecular alterations associated with oral squamous cell cancer
    Perez-Sayans, Mario
    Manuel Somoza-Martin, Jose
    Barros-Angueira, Francisco
    Dolores Reboiras-Lopez, Maria
    Gandara Rey, Jose Manuel
    Garcia-Garcia, Abel
    ONCOLOGY REPORTS, 2009, 22 (06) : 1277 - 1282
  • [28] Cell pathways targets cancer
    Gain, B
    GENETIC ENGINEERING NEWS, 1999, 19 (18): : 22 - +
  • [29] Revealing the Molecular Mechanism of Gastric Cancer Marker Annexin A4 in Cancer Cell Proliferation Using Exon Arrays
    Lin, Li-Ling
    Huang, Hsuan-Cheng
    Juan, Hsueh-Fen
    PLOS ONE, 2012, 7 (09):
  • [30] Molecular Pathways: Dysregulated Glutamatergic Signaling Pathways in Cancer
    Prickett, Todd D.
    Samuels, Yardena
    CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4240 - 4246